Invitation to presentation in connection with EQL Pharma's interim report, first quarter, 2026/27
EQL Pharma AB (publ) will publish its interim report for the first quarter, 2026/27, on Friday, 7th August.
At 10.00 (CET) 7th August, the company will give a presentation via video conference. The presentation is aimed at shareholders and potential shareholders. CEO and President Axel Schörling presents and comments on the interim report. After the presentation, there is an opportunity to ask questions for those who participate.
Use the following link to access the virtual meeting: https://tinyurl.com/nj5tmxzh
Date and time
August 7th, 2026, at 10.00 (CET) the presentation starts. Time required for presentation and subsequent question time is estimated at a maximum 1 hour.
Make sure you are able to attend the video conference by logging in shortly before the start of the conference.
For more information contact:
Axel Schörling,
CEO & President EQL Pharma AB (publ)
Phone: +46 (0) 76 317 90 60
E-mail: axel.schorling@eqlpharma.com
Web: www.eqlpharma.com